Akebia Therapeutics

1. AKB-097 Ph2 start2H 2026AKB-097 Ph2 start, 2H 2026, routine
2. AKB-9090 Ph1 toplineend of 2026 or early 2027AKB-9090 Ph1 topline, end of 2026 or early 2027, major
3. Vafseo VOCAL topline4Q 2026Vafseo VOCAL topline, 4Q 2026, thesis-defining
4. Vafseo VOICE toplineEarly 2027Vafseo VOICE topline, Early 2027, major
5. AKB-097 readout2027AKB-097 readout, 2027, material
6. Term loan financingJan 1, 2027Term loan financing, Jan 1, 2027, routine

Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.